News Releases

Study: Gemcitabine helps prevent recurrence of low-grade bladder cancer

May 8, 2018

SAN ANTONIO (May 8, 2018) ― A multi-institution clinical trial involving researchers from UT Health San Antonio shows significantly lower recurrence of bladder cancer in patients who received the chemotherapy drug gemcitabine. The results of the trial were published May 8, 2018, in the Journal of the American Medical Association. Robert Svatek, M.D., a UT […]

Read more

2017 ceremony

Students, faculty to give thanks for body donors

May 2, 2018

Annual ceremony is open to the public WHAT:           2018 Burial of the Ashes Ceremony, a commemoration of the contributions of body donors to the educational mission of The University of Texas Health Science Center (now called UT Health San Antonio) WHEN:           5:30 p.m. today (May 2) WHERE:         Memorial Park, Greehey Academic & Research Campus of […]

Read more

Lisa Cleveland, Ph.D., RN, and boxes of Narcan, which can reverse an opioid overdose.

UT Health San Antonio School of Nursing leads training to save lives of opioid users

April 26, 2018

SAN ANTONIO (April 26, 2018) ― The UT Health San Antonio School of Nursing has been awarded two grants totaling more than $4 million to educate Bexar County first responders in how to identify and reverse opioid overdose. Lisa Cleveland, Ph.D., RN, assistant professor of nursing, received the grants from the Texas Health & Human […]

Read more

Dementia trend shows later onset with fewer years of the disease

April 20, 2018

The diagnosis is one that a family never wants to hear: Your father has Alzheimer’s disease. Your mother has stroke-related dementia. A recently released study, included in a special supplement to the Journal of Gerontology, indicates that dementia’s impact might be compressing a bit. That is, people might be developing dementia later and living with […]

Read more

Expert panel recommends CBD medication for use in 2 epilepsies

April 19, 2018

Dr. Jose Cavazos of UT Health San Antonio serves on FDA advisory committee. A U.S. Food and Drug Administration advisory committee on April 19 recommended approval of the first cannabidiol (CBD) medicine for prescription use in two severe pediatric epilepsy syndromes. The vote was 13-0. Jose E. Cavazos, M.D., Ph.D., professor of neurology and physiology […]

Read more

Pancreatic cancer research method

Injecting gene cocktail into mouse pancreas leads to humanlike tumors

April 4, 2018

Novel technology developed at UT Health San Antonio gives rise to mouse pancreatic tumors that have the same traits as human pancreatic cancer. A U.S. patent is pending on the invention. The groundbreaking technology, reported in February in the journal Carcinogenesis (Oxford University Press), could revolutionize studies of pancreatic cancer initiation and progression, and spur […]

Read more